PAA 3.03% 17.0¢ pharmaust limited

Ann: First Patient Dosed in MND Phase 1/2 Trial, page-126

  1. 1,058 Posts.
    lightbulb Created with Sketch. 2063
    Hi Paralogical and Dryasachip.

    Riluzole is the drug normally given to MND patients, it reduces electricity impulses to the brains synapses. It stops the shakes.

    It increases life expectancy by 6 to 19 months ..

    The clearance of degraded cells in the body is reliant on 3 main pathways.We have one in MPL (P13K) , Riluzole has a another pathway in Beclin1

    Beclin1 isolates the old cells for clearance ( the rubbish in the garbage can ) MPL activates the truck to pick up said can. We need both for absolute clearance.

    Have a look at the figures in this study .

    Regulation of macroautophagy by mTOR and Beclin1 complexes. Cotongo 2008.
    Last edited by kpax: 14/11/22
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
17.0¢
Change
0.005(3.03%)
Mkt cap ! $82.65M
Open High Low Value Volume
17.0¢ 18.0¢ 16.8¢ $151.1K 877.6K

Buyers (Bids)

No. Vol. Price($)
4 54714 17.0¢
 

Sellers (Offers)

Price($) Vol. No.
18.0¢ 371375 7
View Market Depth
Last trade - 16.10pm 16/08/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.